Is Silgan Holdings (SLGN) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • 4 hours ago

Here's Why Silgan Holdings (SLGN) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Jun 9, 2026

Why Is Silgan (SLGN) Down 6.3% Since Last Earnings Report?

Silgan (SLGN) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • May 29, 2026

Silgan Declares Quarterly Dividend

NORWALK, Conn.--(BUSINESS WIRE)--SILGAN DECLARES QUARTERLY DIVIDEND.

Business Wire • May 12, 2026

Silgan Holdings Inc. (SLGN) Q1 2026 Earnings Call Transcript

Silgan Holdings Inc. (SLGN) Q1 2026 Earnings Call Transcript

Seeking Alpha • Apr 29, 2026

Silgan Announces First Quarter 2026 Results

NORWALK, Conn.--(BUSINESS WIRE)--SILGAN ANNOUNCES FIRST QUARTER 2026 RESULTS.

Business Wire • Apr 29, 2026

Silgan (SLGN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Silgan (SLGN) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research • Apr 29, 2026

Silgan Holdings (SLGN) Q1 Earnings and Revenues Top Estimates

Silgan Holdings (SLGN) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.82 per share a year ago.

Zacks Investment Research • Apr 29, 2026

Analysts Estimate Silgan Holdings (SLGN) to Report a Decline in Earnings: What to Look Out for

Silgan (SLGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Apr 22, 2026

Gerresheimer rejects takeover bid from US packing firm Silgan, say sources

German medical packaging maker Gerresheimer has rejected ​a takeover bid from its ‌U.S. rival Silgan , three sources familiar with the situation told ​Reuters.

Reuters • Apr 17, 2026